Learn more about breast cancer screening and the importance of mammograms, featuring Dr. Anupama Acheson from Providence Cancer Center.
A first-of-its-kind clinical study may offer new hope to patients battling rectal cancer.
The Phase 2 study, newly underway at Providence Cancer...
Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer...
Two new studies of investigational and FDA-approved immunotherapies for advanced melanoma are opening soon at Providence Cancer Center.
With the release of her book Patient 71, Australia native Julie Randall has given cancer patients across the globe hope for life after cancer. Her remarkable story of overcoming stage IV metastatic melanoma was featured in a segment by 60 Minutes Australia chronicling her shocking diagnosis, promise to her family and determination to become “Patient 71” in an immunotherapy clinical trial at Providence Cancer Center.
Known as "Patient 71," persistence paid off for Australian cancer patient Julie Randall
Learn more about her story ›
She now devotes her...
Two studies at Providence Cancer Center are focusing on patients’ genomes to help identify the most effective targeted anti-cancer therapies.
It has been a busy and exciting start to 2017 for immunotherapy researcher Eric Tran, Ph.D., and it could make a great difference in the lives of people fighting cancer.
More than 20 studies of promising new therapies for lung cancer patients are open now at Providence Cancer Center, including studies of targeted therapies and novel immunotherapy combinations.
Immunotherapy is a treatment approach that harnesses the immune system to recognize, attack and eliminate cancer.
The opportunity to conduct...